Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200)
Public ClinicalTrials.gov record NCT02395172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Open-Label, Multicenter Trial of Avelumab (MSB0010718C) Versus Docetaxel in Subjects With Non-Small Cell Lung Cancer That Has Progressed After a Platinum-Containing Doublet
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study was to demonstrate superiority with regard to overall survival of avelumab versus docetaxel in participants with programmed death ligand 1 (PD-L1) positive, non-small cell lung cancer (NSCLC) after failure of a platinum-based doublet.
Study identification
- NCT ID
- NCT02395172
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 792 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 23, 2015
- Primary completion
- Nov 21, 2017
- Completion
- Dec 2, 2019
- Last update posted
- Aug 2, 2020
2015 – 2019
United States locations
- U.S. sites
- 27
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama | Tuscaloosa | Alabama | 35401 | — |
| Mayo Clinic | Scottsdale , Phoenix | Arizona | 85259-5499 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Healing Hands Oncology and Medical Care | Lawndale | California | 90260 | — |
| Sutter Gould Medical Foundation | Modesto | California | 95355 | — |
| Sharp Memorial Hospital | San Diego | California | 92123 | — |
| Lynn Cancer Institute Center | Boca Raton | Florida | 33486 | — |
| University Cancer Institute | Boynton Beach | Florida | 33426 | — |
| Holy Cross Hospital Inc. | Fort Lauderdale | Florida | 33308 | — |
| Florida Cancer Specialists-Broadway | Fort Myers | Florida | 33916 | — |
| Florida Cancer Specialists | St. Petersburg | Florida | 33705 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | 33401 | — |
| Northeast Georgia Cancer Care, LLC | Athens | Georgia | 30607 | — |
| Metairie Oncologist, LLC | Metairie | Louisiana | 70006 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Hematology Oncology Associates of Rockland | Nyack | New York | 10960 | — |
| Novant Health Oncology Specialists | Winston-Salem | North Carolina | 27103 | — |
| Oncology Hematology Care | Cincinnati | Ohio | 45242 | — |
| Signal Point Clinical Research Center | Middletown | Ohio | 45042 | — |
| Mercy Clinic Oklahoma Communities, Inc. | Oklahoma City | Oklahoma | 73120-9309 | — |
| Abington Memorial Hospital | Abington | Pennsylvania | 19001 | — |
| Penn State Univ. Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Center for Biomedical Research, LLC | Knoxville | Tennessee | 37909 | — |
| SCRI - Tennessee Oncology | Nashville | Tennessee | 37203 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| University of Texas Health Science Center at Tyler | Tyler | Texas | 75708 | — |
| MultiCare Health System | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 233 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02395172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 2, 2020 · Synced Sep 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02395172 live on ClinicalTrials.gov.